Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancer

Oncogene

Volumn 19, Issue 27, 2000, Pages 3078-3085

  Giannakakou, Paraskevi ^a   Poy, George ^b   Zhan, Zhirong ^a   Knutsen, Turid ^a   Blagosklonny, Mikhail V ^a   Fojo, Tito ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Drug resistance; Human cancer; P53; Paclitaxel; Tubulin

Indexed keywords

MESSENGER RNA; PACLITAXEL; PROTEIN P53; TUBULIN;

ARTICLE; CANCER; CELL LINE; CODON; CONTROLLED STUDY; DNA BINDING; DRUG EFFICACY; DRUG SENSITIVITY; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MUTANT; OVARY CARCINOMA; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL;

EID: 0034702273     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203642     Document Type: Article

References (33)

1. Blagosklonny MV (1997). Oncogene, 15, 1889-1893.
2. Blagosklonny M V and el-Deiry WS. (1996). Int. J. Cancer, 67, 386-392.
3. Blagosklonny MV, Giannakakou P, Wojtowicz M, Romanova LY, Ain KB, Bates SE and Fojo T. (1998). J. Clin. Endocrinol. Metab., 83, 2516-2522.
4. Brachmann RK, Vidal M and Boeke JD. (1996). Proc. Natl. Acad. Sci. USA, 93, 4091-4095.
5. Cahill DP, Kinzler KW, Vogelstein B and Lengauer C. (1999). Trends Cell Biol., 9, 57-60.
6. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH and Reid BJ. (1995). Science, 267, 1353-1356.
7. Debernardis D, Sire EG, De Feudis P, Vikhanskaya F, Valenti M, Russo P, Parodi S, D'Incalci M and Broggini M. (1997). Cancer Res., 57, 870-874.
8. Dumontet C and Sikic BI. (1999). J. Clin. Oncol., 17, 1061-1070.
9. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. (1993). Cell, 75, 817-825.
10. Fan S, Cherney B, Reinhold W, Rucker K and O'Connor PM. (1998). Clin. Cancer Res., 4, 1047-1054.
11. Fukasawa K, Choi T, Kuriyama R, Rulong S and Vande WG. (1996). Science, 271, 1744-1747.
12. Gan Y, Wientjes MG, Schuller DE and Au JL. (1996). Cancer Res., 56, 2086-2093.
13. Giannakakou P, Sackett DL, Kang YK, Zhan Z, Buters JT, Fojo T and Poruchynsky MS. (1997). J. Biol. Chem., 272, 17118-17125.
14. Giannakakou P, Gussio R, Nogales E, Downing KH, Zaharevitz D, Bollbuck B, Poy G, Sackett D, Nicolaou KC and Fojo T. (2000). Proc. Natl. Acad. Sci. USA, 97, 2910-2915
15. Hartwell L. (1992). Cell, 71, 543-546.
16. Havre PA, Yuan J, Hedrick L, Cho KR and Glazer PM. (1995). Cancer Res., 55, 4420-4424.
17. Hsiao M, Low J, Dorn E, Ku D, Pattengale P, Yeargin J and Haas M. (1994a). Am. J. Pathol., 145, 702-714.
18. Hsiao MH, Yu AL, Yeargin J, Ku D and Haas M. (1994b). Blood, 83, 2922-2930.
19. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW. (1991). Cancer Res., 51, 6304-6311.
20. Lengauer C, Kinzler KW and Vogelstein B. (1998). Nature, 396, 643-649.
21. Levine AJ. (1997). Cell, 88, 323-331.
22. Liu PK, Kraus E, Wu TA, Strong LC and Tainsky MA. (1996). Oncogene, 12, 2267-2278.
23. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE and Jacks T. (1994). Science, 266, 807-810.
24. Miyashita T and Reed JC. (1995). Cell, 80, 293-299.
25. Monzo M, Rosell R, Sanchez JJ, Lee JS, O'Brate A, Gonzalez-Larriba JL, Alberola V, Lorenzo JC, Nunez L, Ro JY and Martin C. (1999). J. Clin. Oncol., 17, 1786-1793.
26. Murphy LD, Herzog CE, Rudick JB, Fojo AT and Bates SE. (1990). Biochemistry, 29, 10351-10356.
27. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S and Devilee P. (1989). Nature, 342, 705-708.
28. O'Connor PM, Jackman J, Bae I, Myers TG, Fan S, Mutoh M, Scudiero DA, Monks A, Sausville EA, Weinstein JN, Friend S, Fornace AJJ and Kohn KW. (1997). Cancer Res., 57, 4285-4300.
29. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S and Boyd MR. (1990). J. Natl. Cancer Inst., 82, 1107-1112.
30. Vasey PA, Jones NA, Jenkins S, Dive C and Brown R. (1996). Mol. Pharmacol., 50, 1536-1540.
31. Wahl, AF, Donaldson, KL, Fairchild, C, Lee, FY, Foster, SA, Demers, GW and Galloway, DA. (1996). Nat. Med., 2, 72-79.
32. Weinstein JN, Myers TG, O'Connor PM, Friend SH, Fornace AJJ, Kohn KW, Fojo T, Bates SE, Rubinstein LV, Anderson NL, Buolamwini JK, van Osdol WW, Monks AP, Scudiero DA, Sausville EA, Zaharevitz DW, Bunow B, Viswanadhan VN, Johnson GS, Wittes RE and Paull KD. (1997). Science, 275, 343-349.
33. Zhang CC, Yang JM, White E, Murphy M, Levine A and Hait WN. (1998). Oncogene, 16, 1617-1624.